On January 20, 2022 Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, reported that James Dentzer, President and Chief Executive Officer, will participate in the following upcoming conferences (Press release, Curis, JAN 20, 2022, View Source [SID1234605620]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

B. Riley Virtual Oncology Conference, Thursday, January 27, 2022 at 1:30 p.m. ET

SVB Leerink 11th Annual Global Healthcare Conference, Friday, February 18, 2022 at 11:20 a.m. ET

Live webcasts of the presentations will be available under "Events & Presentations" in the Investors section of the Company’s website at www.curis.com. Archived replays of the webcasts will be available on the Curis website for 90 days following the event.